These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17385436)

  • 1. [Procedure for determination of oxidative modification of plasma fibrinogen].
    Ragino IuI; Baum VA; Polonskaia IaV; Gromov AA
    Klin Lab Diagn; 2007 Jan; (1):13-6. PubMed ID: 17385436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A procedure for determining the oxidative modification of apolipoproteins in low-density lipoproteins].
    Ragino IuI; Polonskaia IaV; Sadovskiĭ EV
    Klin Lab Diagn; 2007 Jun; (6):14-7. PubMed ID: 17682473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oxidized fibrinogen and its relationship with hemostasis disturbances and endothelial dysfunction during coronary heart disease and myocardial infarction].
    Ragino IuI; Baum VA; Polonskaia IaV; Baum SR; Nikitin IuP
    Kardiologiia; 2009; 49(9):4-8. PubMed ID: 19772496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between oxidized fibrinogen and hemostasis disturbances and endothelial dysfunction in myocardial infarction.
    Ragino YI; Baum VA; Polonskaya YV; Sadovski EV; Baum SR; Nikitin YP
    Bull Exp Biol Med; 2008 Apr; 145(4):412-4. PubMed ID: 19110580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction.
    Becatti M; Marcucci R; Bruschi G; Taddei N; Bani D; Gori AM; Giusti B; Gensini GF; Abbate R; Fiorillo C
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1355-61. PubMed ID: 24790138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative modification of fibrinogen inhibits its transformation into fibrin under the effect of thrombin.
    Azizova OA; Piryazev AP; Aseychev AV; Shvachko AG
    Bull Exp Biol Med; 2009 Feb; 147(2):201-3. PubMed ID: 19513421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oxidation-modified fibrinogen on the formation and lysis of fibrin clot in the plasma.
    Piryazev AP; Aseichev AV; Azizova OA
    Bull Exp Biol Med; 2009 Dec; 148(6):881-5. PubMed ID: 21116496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin self-assembly is adapted to oxidation.
    Rosenfeld MA; Bychkova AV; Shchegolikhin AN; Leonova VB; Kostanova EA; Biryukova MI; Sultimova NB; Konstantinova ML
    Free Radic Biol Med; 2016 Jun; 95():55-64. PubMed ID: 26969792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
    ; Danesh J; Lewington S; Thompson SG; Lowe GD; Collins R; Kostis JB; Wilson AC; Folsom AR; Wu K; Benderly M; Goldbourt U; Willeit J; Kiechl S; Yarnell JW; Sweetnam PM; Elwood PC; Cushman M; Psaty BM; Tracy RP; Tybjaerg-Hansen A; Haverkate F; de Maat MP; Fowkes FG; Lee AJ; Smith FB; Salomaa V; Harald K; Rasi R; Vahtera E; Jousilahti P; Pekkanen J; D'Agostino R; Kannel WB; Wilson PW; Tofler G; Arocha-Piñango CL; Rodriguez-Larralde A; Nagy E; Mijares M; Espinosa R; Rodriquez-Roa E; Ryder E; Diez-Ewald MP; Campos G; Fernandez V; Torres E; Marchioli R; Valagussa F; Rosengren A; Wilhelmsen L; Lappas G; Eriksson H; Cremer P; Nagel D; Curb JD; Rodriguez B; Yano K; Salonen JT; Nyyssönen K; Tuomainen TP; Hedblad B; Lind P; Loewel H; Koenig W; Meade TW; Cooper JA; De Stavola B; Knottenbelt C; Miller GJ; Cooper JA; Bauer KA; Rosenberg RD; Sato S; Kitamura A; Naito Y; Palosuo T; Ducimetiere P; Amouyel P; Arveiler D; Evans AE; Ferrieres J; Juhan-Vague I; Bingham A; Schulte H; Assmann G; Cantin B; Lamarche B; Després JP; Dagenais GR; Tunstall-Pedoe H; Woodward M; Ben-Shlomo Y; Davey Smith G; Palmieri V; Yeh JL; Rudnicka A; Ridker P; Rodeghiero F; Tosetto A; Shepherd J; Ford I; Robertson M; Brunner E; Shipley M; Feskens EJ; Kromhout D; Dickinson A; Ireland B; Juzwishin K; Kaptoge S; Lewington S; Memon A; Sarwar N; Walker M; Wheeler J; White I; Wood A
    JAMA; 2005 Oct; 294(14):1799-809. PubMed ID: 16219884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial infarction in patients aged less than 40 years. Frequency of BclI polymorphism in the fibrinogen beta-chain gene and plasma fibrinogen.
    Lewandowski K; Kwaśnikowski P; Elikowski W; Zawilska K
    Kardiol Pol; 2003 Sep; 59(9):205-12. PubMed ID: 14618197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ferritin and other acute phase proteins in various forms of coronary heart disease].
    Paramonov AD; Moiseev SV; Fomin VV; Kopelëva MV; Stankevich LI; Martynov AI; Mukhin NA
    Klin Med (Mosk); 2005; 83(2):25-9. PubMed ID: 15803827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assay of oxidized fibrinogen reactivity (OFR) as a biomarker of oxidative stress in human plasma: the role of lysine analogs.
    Selmeci L; Seres L; Székely M; Soós P; Acsády G
    Clin Chem Lab Med; 2010 Mar; 48(3):379-82. PubMed ID: 20113253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fibrinogen on lipid peroxidation in patients with coronary heart disease and in vitro.
    Savchenkova AP; Dudnik LB; Pogoretskaya IL; Solov'eva NP; Pokrovskaya MA; Aseichev AV; Drinitsyna SV; Azizova OA; Lopukhin YM
    Bull Exp Biol Med; 2003 Jan; 135(1):29-33. PubMed ID: 12717506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance of the fibrinogen concentration as an independent risk factor for ischemic heart disease].
    Hummel L
    Wien Med Wochenschr; 1993; 143(18):469-72. PubMed ID: 8310700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of fibrinogen measurements in post-myocardial infarction patients. Results from the AIRGENE study center Augsburg.
    Baumert J; Karakas M; Greven S; Rückerl R; Peters A; Koenig W
    Thromb Haemost; 2012 May; 107(5):895-902. PubMed ID: 22399014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction.
    Gardemann A; Schwartz O; Haberbosch W; Katz N; Weiss T; Tillmanns H; Hehrlein FW; Waas W; Eberbach A
    Thromb Haemost; 1997 Jun; 77(6):1120-6. PubMed ID: 9241743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human blood plasma advanced oxidation protein products (AOPP) correlates with fibrinogen levels.
    Selmeci L; Székely M; Soós P; Seres L; Klinga N; Geiger A; Acsády G
    Free Radic Res; 2006 Sep; 40(9):952-8. PubMed ID: 17015275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of a prothrombotic state with left-ventricular diastolic dysfunction in hypertension: a tissue-Doppler imaging study.
    Catena C; Colussi G; Fedrizzi S; Sechi LA
    J Hypertens; 2013 Oct; 31(10):2077-84. PubMed ID: 24107736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive metabolomics identified lipid peroxidation as a prominent feature in human plasma of patients with coronary heart diseases.
    Lu J; Chen B; Chen T; Guo S; Xue X; Chen Q; Zhao M; Xia L; Zhu Z; Zheng L; Yin H
    Redox Biol; 2017 Aug; 12():899-907. PubMed ID: 28472752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction.
    Mannila MN; Eriksson P; Ericsson CG; Hamsten A; Silveira A
    Thromb Haemost; 2006 Mar; 95(3):420-7. PubMed ID: 16525568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.